Clinical practice guidelines for the treatment of lung cancer

From Cancer Guidelines Wiki


Please note there are further questions under development for this guideline and they will be released for public consultation and published in a staged approach. To be notified about updates, please email guidelines (at) cancer.org.au.


See also: Clinical practice guidelines for the prevention and diagnosis of lung cancer.

Clinical practice guidelines for the treatment of lung cancer


Foreword

Summary of recommendations (Printable version)

Non small-cell lung cancer (NSCLC) – stage I operable

Surgery

Radiotherapy

Chemotherapy


NSCLC – stage I inoperable

Surgery

Radiotherapy

Chemotherapy


NSCLC – stage II operable

Surgery

Radiotherapy

Chemotherapy


NSCLC – stage II inoperable

Radiotherapy

Chemotherapy


NSCLC – stage III operable

Surgery

Radiotherapy

Chemotherapy


NSCLC – stage III inoperable

Single and multimodality therapies


NSCLC – stage IV operable

Surgery

Radiotherapy


NSCLC – stage IV inoperable

Radiotherapy

Chemotherapy


Small cell lung cancer (SCLC) – limited stage

Chemotherapy

Radiotherapy


SCLC – extensive stage

Chemotherapy

Radiotherapy

Palliative care

Supportive care

Questions under development

  • What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?
  • What is the role of immunotherapy in “unselected” patients with stage IV NSCLC?
  • What is the role of immunotherapy in selected patients by PDL1 staining percentage in tumours (by immunohistochemistry)?
  • What is the optimal systemic therapy regimen in selected patients for treatment of stage IV inoperable NSCLC?

Appendices

Further information for health professionals

Investigating symptoms of lung cancer: a guide for GPs

Information for consumers

Understanding Lung Cancer

General comments

Please provide general comments regarding this guideline by using the comment button below.